$2.31T
Total marketcap
$127.31B
Total volume
BTC 49.73%     ETH 15.77%
Dominance

The United Laboratories International Holdings Limited UNJ.F Stock

1.14 EUR {{ price }} -0.869564% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.1B EUR
LOW - HIGH [24H]
1.14 - 1.15 EUR
VOLUME [24H]
1.55K EUR
{{ volume }}
P/E Ratio
6.00
Earnings per share
0.19 EUR

The United Laboratories International Holdings Limited Price Chart

The United Laboratories International Holdings Limited UNJ.F Financial and Trading Overview

The United Laboratories International Holdings Limited stock price 1.14 EUR
Previous Close 0.83 EUR
Open 0.83 EUR
Bid 0.82 EUR x 800000
Ask 0.88 EUR x 600000
Day's Range 0.82 - 0.83 EUR
52 Week Range 0.39 - 0.87 EUR
Volume 3.94K EUR
Avg. Volume 81 EUR
Market Cap 1.53B EUR
Beta (5Y Monthly) 0.388505
PE Ratio (TTM) 7.4545455
EPS (TTM) 0.19 EUR
Forward Dividend & Yield 0.03 (3.20%)
Ex-Dividend Date July 4, 2023
1y Target Est N/A

UNJ.F Valuation Measures

Enterprise Value -779892160 EUR
Trailing P/E 7.4545455
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.13473473
Price/Book (mrq) 0.14045906
Enterprise Value/Revenue -0.069
Enterprise Value/EBITDA -0.307

Trading Information

The United Laboratories International Holdings Limited Stock Price History

Beta (5Y Monthly) 0.388505
52-Week Change 47.32%
S&P500 52-Week Change 20.43%
52 Week High 0.87 EUR
52 Week Low 0.39 EUR
50-Day Moving Average 0.73 EUR
200-Day Moving Average 0.56 EUR

UNJ.F Share Statistics

Avg. Volume (3 month) 81 EUR
Avg. Daily Volume (10-Days) 394 EUR
Shares Outstanding 1.82B
Float 902.14M
Short Ratio N/A
% Held by Insiders 50.35%
% Held by Institutions 8.93%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.19
Trailing Annual Dividend Yield 22.89%
5 Year Average Dividend Yield 206.00%
Payout Ratio 0.1511
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 13.94%
Operating Margin (ttm) 17.77%
Gross Margin 43.84%
EBITDA Margin 22.39%

Management Effectiveness

Return on Assets (ttm) 7.13%
Return on Equity (ttm) 15.84%

Income Statement

Revenue (ttm) 11.33B EUR
Revenue Per Share (ttm) 6.23 EUR
Quarterly Revenue Growth (yoy) 23.40%
Gross Profit (ttm) N/A
EBITDA 2.54B EUR
Net Income Avi to Common (ttm) 1.58B EUR
Diluted EPS (ttm) 0.11
Quarterly Earnings Growth (yoy) 160.69%

Balance Sheet

Total Cash (mrq) 4.74B EUR
Total Cash Per Share (mrq) 2.61 EUR
Total Debt (mrq) 2.46B EUR
Total Debt/Equity (mrq) 23.21 EUR
Current Ratio (mrq) 1.779
Book Value Per Share (mrq) 5.838

Cash Flow Statement

Operating Cash Flow (ttm) 2.03B EUR
Levered Free Cash Flow (ttm) 619.01M EUR

Profile of The United Laboratories International Holdings Limited

Country Germany
State N/A
City Yuen Long
Address 6 Fuk Wang Street
ZIP N/A
Phone 852 2687 1033
Website https://www.tul.com.cn
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 14000

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules, as well as active pharmaceutical ingredients and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.

Q&A For The United Laboratories International Holdings Limited Stock

What is a current UNJ.F stock price?

The United Laboratories International Holdings Limited UNJ.F stock price today per share is 1.14 EUR.

How to purchase The United Laboratories International Holdings Limited stock?

You can buy UNJ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for The United Laboratories International Holdings Limited?

The stock symbol or ticker of The United Laboratories International Holdings Limited is UNJ.F.

Which industry does the The United Laboratories International Holdings Limited company belong to?

The The United Laboratories International Holdings Limited industry is Drug Manufacturers-Specialty & Generic.

How many shares does The United Laboratories International Holdings Limited have in circulation?

The max supply of The United Laboratories International Holdings Limited shares is 1.84B.

What is The United Laboratories International Holdings Limited Price to Earnings Ratio (PE Ratio)?

The United Laboratories International Holdings Limited PE Ratio is 6.00000000 now.

What was The United Laboratories International Holdings Limited earnings per share over the trailing 12 months (TTM)?

The United Laboratories International Holdings Limited EPS is 0.19 EUR over the trailing 12 months.

Which sector does the The United Laboratories International Holdings Limited company belong to?

The The United Laboratories International Holdings Limited sector is Healthcare.